Diversigen nabs Novartis veteran for board position; MediVet opens second U.S. lab; Valneva teams with Fatro for veterinary vaccines;

> Diversigen, which provides microbiome and metagenomic services to the animal health industry, appointed George Gunn, formerly of Novartis ($NVS) Animal Health, to its board of directors. Release

> Regenerative medicine company MediVet Biologics announced it will open its second U.S. laboratory in Manhattan, KS, this October. Release

> Vaccine maker Valneva of France signed a licensing agreement with Italian pharmaceutical company Fatro to develop and commercialize two veterinary vaccines using its EB66 cells. Release

> India's Lyka Labs announced it is selling its animal health division to Alivira Animal Health for an undisclosed sum. Article

> A new report from BCC Research predicts that the U.S. market for pet care products and services will grow at a compound annual rate of 2.5% through 2020 to $69.4 billion. Release

> Premune has formed a licensing agreement with Innovet Italia to bring its product Redonyl Ultra, a skin supplement for dogs and cats, to European markets outside of Italy, with an option to introduce the product in North America. Release